cancer

Dear Research Advocate: After Tuesday’s election, we may or may not know the exact composition of the 116th Congress, as there are likely to be some very, very close races. But there is little doubt that the picture will be clearer than it is now when it comes to the policy dynamics next year -- and that is what our post-election briefing on Thursday, November 8 from 10:00 to 11:30 a.m. EST at AAAS (1200 New York Ave, NW in Washington, DC) is all about. Register now! If history is any guide, the magnitude of change in Congress will affect the prospects for completing unfinished business during the lame-duck session of Congress; not surprisingly, the more turnover, the harder it is to build...
A tsunami of cancer threatens livelihoods across the globe, and the world is largely unprepared for its impact. The disease accounts for one out of every seven deaths worldwide – more than HIV/AIDS, tuberculosis and malaria combined . Nearly 60% of the world’s cancer cases occur in low- and middle-income countries (LMICs), and these regions account for about 65% of the world’s cancer deaths . Reducing these disparities requires comprehensive and complementary approaches, and engaging with partners. The American Cancer Society’s global cancer control team has – through in-country research and collaborative partnerships – developed responsive and sustainable initiatives around cancer...
Dear Research Advocate: Americans spent $8.4 billion on Halloween in 2016 -- and no doubt will spend even more this year-- enough to fund the Agency for Healthcare Research and Quality (AHRQ) for 17+ years! What we spend to improve the quality of health care delivery represents only about 0.012% of the $3.3 trillion we spend on health care. Stats like these help place research -- in this case health services research (HSR) -- spending into perspective. (For more advocacy-relevant info, see our fact sheet .) The vision for AHRQ that Director Gopal Khanna shares in this terrific blog post underscores why a far greater investment in HSR makes strategic sense for our nation. More on what money...
This article is the sixth in a series highlighting the accomplishments of Research!America’s 2017 Advocacy Award honorees who will be saluted at a dinner in Washington, D.C., on March 15. More details can be found here . Nearly 1.7 million Americans were diagnosed with cancer last year. National expenditures for care are estimated to rise to $156 billion in 2020. Cancer is the second leading cause of death in the United States, claiming more than half-a-million lives each year. Joseph R. Biden, Jr., 47 th Vice President of the United States, is leading efforts to accelerate the pace of cancer research through collaboration and innovative partnerships, and has been hailed as the driving...
This article is the fourth in a series highlighting the accomplishments of Research!America’s 2017 Advocacy Award honorees who will be saluted at a dinner in Washington, D.C., on March 15. More details can be found here . Nobel laureate Phillip A. Sharp, Ph.D., is Research!America’s recipient of the Raymond and Beverly Sackler Award for Sustained National Leadership , which honors medical and health research advocacy leaders who have been instrumental in developing and implementing a sustained advocacy program for medical and health research. Prof. Sharp is an Institute Professor at the Massachusetts Institute of Technology and serves as Chair of Stand Up To Cancer’s (SU2C) Scientific...
Ahead of World Cancer Day on February 4, the American Association for Cancer Research (AACR) would like to thank the thousands of laboratory researchers, physician-scientists, healthcare professionals and patient advocates around the globe and recognize their commitment to increasing the number of cancer survivors who are alive today. In the U.S., thanks to decades of federally funded cancer research supported by the National Institutes of Health (NIH) and the National Cancer Institute (NCI), we have seen a steady rise in the number of Americans who survive a cancer diagnosis. Our continued commitment to preventing and curing cancer comes at a time when, despite all the incredible progress...
As World Cancer Day approaches, Moffitt Cancer Center remains committed to supporting research that addresses the health care needs of LGBTQ patients who are at-risk or suffering from cancer. The lesbian, gay, bisexual, transgender and queer/questioning (LGBTQ) community, also referred to as sexual and gender minorities (SGMs), is a growing and medically underserved population in the United States. It spans all races, ethnicities, ages, socioeconomic statuses, and regions of the United States and accounts for roughly 3% to 12% of the adult population. LGBTQ individuals have higher disease risk and worse health outcomes for many diseases than heterosexual and cisgender (having a gender...
Gregg Gordon was 44 and the picture of health until he suddenly became excessively tired and noticed two small bumps on his shin. A visit to his doctor led to a startling cancer diagnosis, and less than 24 hours later he was receiving chemotherapy to treat acute myeloid leukemia. When standard treatments failed, Gregg’s best hope was a bone marrow transplant, but he could not find a donor match. Fortunately, he was referred to Colleen Delaney, M.D., in Seattle, who had developed a process for expanding stem cells from umbilical cord blood for use in patients without donors. As The Washington Post reported in September 2016, the procedure was a success and Gregg has been cancer-free for five...
In the U.S., it is estimated that 1 in 2 men and 1 in 3 women will develop cancer in their lifetime even though 50% of cancer deaths are preventable. The Bipartisan Policy Center (BPC) and the American Cancer Society Cancer Action Network hosted a panel on Friday, September 30 in Washington, D.C. on the future of cancer prevention with top public health experts. “We cannot achieve the full potential in our cancer fight unless we embrace and implement everything we have learned about prevention,” said Dr. Richard Wender, the American Cancer Society’s Chief Cancer Control Officer, and keynote speaker. Of the 26% decline in cancer death rates among women in the United States from 1930-2012, he...
The American Association for Cancer Research (AACR) has released the annual Cancer Progress Report , highlighting advances in cancer research, as well as advocating for sustained and robust funding for federal health agencies. AACR also hosted a congressional briefing on the progress report on Wednesday, September 21 to bring to Congress’ attention the importance of funding for research and emphasized patient involvement in moving research forward. Patient participation in clinical trials is important not only to test the efficacy of cancer drugs, but also to further the precision medicine initiative that aims to individualize cancer treatment based on each patient’s genetic code and...

Pages